INDIANAPOLIS, Sept. 30, 2013 /PRNewswire/ --
WHAT: Eli Lilly and Company (NYSE: LLY) will host a meeting for the investment community, including major long-term investors, sell-side analysts, financial media and ratings agency representatives.
WHEN: The meeting will take place Thursday, Oct. 3, 2013. The meeting will start at 8:30 a.m. (EDT) and last until approximately 12:30 p.m. (EDT).
WHO: Company leaders will provide an in-depth update of its financial results, its pipeline progress, and its work to sustain a flow of innovative medicines over the long-term. There will be presentations by John C. Lechleiter, Ph.D., chairman, president, and chief operation officer; Derica Rice, chief financial officer; and Jan M. Lundberg, Ph.D., executive vice president of science and technology and president of Lilly Research Laboratories. Lilly's five business presidents also will highlight the significant opportunities in each of their areas. There will Q&A opportunities throughout the meeting.
WHERE: Lilly's investment community meeting will take place at the company's global research and corporate headquarters in Indianapolis, IN.
HOW: A live webcast of the Lilly investment community meeting, along with presentation slides, will be available through a link on Lilly's website at www.lilly.com. The webcast will be available for replay over the next 12 months.
Media interested in attending in-person should contact Edward Sagebiel at (317) 985-6303 or Scott MacGregor at (317) 440-4699. Investors interested in attending should contact Lilly's investor relations department.
About Eli Lilly and Company
Lilly, a leading innovation-driven corporation, is developing a growing portfolio of pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind., Lilly provides answers – through medicines and information ─ for some of the world's most urgent medical needs. Additional information about Lilly is available at www.lilly.com. F-LLY
|SOURCE Eli Lilly and Company|
Copyright©2012 PR Newswire.
All rights reserved